These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 33756233)

  • 1. Protein network exploration prioritizes targets for modulating neuroinflammation in Parkinson's disease.
    Bonte MA; El Idrissi F; Gressier B; Devos D; Belarbi K
    Int Immunopharmacol; 2021 Jun; 95():107526. PubMed ID: 33756233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Computational Exploration of the Molecular Network Associated to Neuroinflammation in Alzheimer's Disease.
    El Idrissi F; Gressier B; Devos D; Belarbi K
    Front Pharmacol; 2021; 12():630003. PubMed ID: 34335238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
    George G; Valiya Parambath S; Lokappa SB; Varkey J
    Gene; 2019 May; 697():67-77. PubMed ID: 30776463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease.
    Roussakis AA; Piccini P
    Int Rev Neurobiol; 2018; 141():347-363. PubMed ID: 30314603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repositioning the existing drugs for neuroinflammation: a fusion of computational approach and biological validation to counter the Parkinson's disease progression.
    Tiwari H; Kumar A; Barik MR; Kaur H; Mahajan S; Shukla MK; Gupta M; Yadav G; Nargotra A
    Mol Divers; 2023 Aug; ():. PubMed ID: 37542020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the contribution of neuroinflammation to Parkinson's disease in humanized immune system mice.
    Manocha GD; Floden AM; Puig KL; Nagamoto-Combs K; Scherzer CR; Combs CK
    Mol Neurodegener; 2017 Feb; 12(1):17. PubMed ID: 28196514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosphingolipids and neuroinflammation in Parkinson's disease.
    Belarbi K; Cuvelier E; Bonte MA; Desplanque M; Gressier B; Devos D; Chartier-Harlin MC
    Mol Neurodegener; 2020 Oct; 15(1):59. PubMed ID: 33069254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.
    Lee Y; Lee S; Chang SC; Lee J
    Arch Pharm Res; 2019 May; 42(5):416-425. PubMed ID: 30830660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-1 attenuates neurodegeneration in Parkinson's disease model by modulating microglial MAPK/IκB/NFκB axis through its carbohydrate-recognition domain.
    Li Y; Chen N; Wu C; Lu Y; Gao G; Duan C; Yang H; Lu L
    Brain Behav Immun; 2020 Jan; 83():214-225. PubMed ID: 31669519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease.
    Kaur K; Gill JS; Bansal PK; Deshmukh R
    J Neurol Sci; 2017 Oct; 381():308-314. PubMed ID: 28991704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia and Parkinson's disease: footprints to pathology.
    Lazdon E; Stolero N; Frenkel D
    J Neural Transm (Vienna); 2020 Feb; 127(2):149-158. PubMed ID: 32016606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
    Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM
    Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?
    Tansey MG; Frank-Cannon TC; McCoy MK; Lee JK; Martinez TN; McAlpine FE; Ruhn KA; Tran TA
    Front Biosci; 2008 Jan; 13():709-17. PubMed ID: 17981581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies.
    Rocha NP; de Miranda AS; Teixeira AL
    Biomed Res Int; 2015; 2015():628192. PubMed ID: 26295044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson's diseases in vivo model.
    Campolo M; Paterniti I; Siracusa R; Filippone A; Esposito E; Cuzzocrea S
    Brain Behav Immun; 2019 Feb; 76():236-247. PubMed ID: 30550933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.
    Kustrimovic N; Marino F; Cosentino M
    Curr Med Chem; 2019; 26(20):3719-3753. PubMed ID: 30306855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advantages of Vasoactive Intestinal Peptide for the Future Treatment of Parkinson's Disease.
    Korkmaz OT; Tunçel N
    Curr Pharm Des; 2018; 24(39):4693-4701. PubMed ID: 30636594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.